← Eichor
Study identifier: NCT01619917 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars

Condition: Burn Scar  ·  Sponsor: University of Manitoba

PhaseNA
Planned participants6
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our assessing the effects of fractional vascular lasers on burn scars. It has been hypothesized that the fractional vascular lasers work on mature scars to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. The retexturing/ resurfacing of the laser theoretically can decrease the visibility of the mesh pattern created by meshed split thickness skin graft). Objective: To determine the benefit of fractional vascular laser treatment in improving burn scar height, texture, vascularity and pliability in late burn scars.

This description comes directly from the study's public registry record.

Talk to the study team

Justin Gawaziuk, MSc  ·  2047893669  ·  jgawaziuk@hsc.mb.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of ManitobaWinnipeg, Manitoba, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01619917